Stock Deal vs. Asset DealBuying the Company or Just Its Parts
The most fundamental structural choice in any M&A deal — do you buy the shares or the assets? The answer shapes taxes, liability exposure, and the entire negotiation dynamic.
What each structure actually means
Share Purchase
The buyer purchases all (or a majority) of the target's shares. This transfers the entire company — assets, liabilities, contracts, permits, and litigation — exactly as it stands.
Asset Purchase
The buyer selectively purchases only the assets they want. Liabilities stay with the selling entity. The buyer gets to cherry-pick what it takes on.
💡 Analogy
A stock deal is buying the whole restaurant — the recipes, the staff, the lease, the inventory, and the debt the previous owner ran up.
An asset deal is buying just the recipes and the kitchen equipment — the previous owner keeps their debt. You take only what you came for.
Pros & Cons — buyer's perspective
The same deal looks completely different depending on which structure you use.
Advantages
Licenses and permits are attached to the corporate entity, so a share transfer automatically passes all rights — no asset-by-asset reassignment needed.
Customer contracts, employment relationships, and supplier agreements carry over intact. No operational disruption on day one.
When a company has thousands of assets, acquiring shares is far faster and cheaper than transferring each asset individually.
Disadvantages
All contingent liabilities — undisclosed lawsuits, environmental obligations, tax assessments — transfer to the buyer. You inherit everything, known and unknown.
Individual sellers pay only capital gains tax on share proceeds. Asset deals create a double-tax problem (corporate tax + dividend tax), so sellers strongly prefer stock deals.
Assets carry over at the target's existing book values. The buyer cannot reset depreciation to current fair market value and loses the related tax shield.
Advantages
The buyer selects specific assets — technology, customer lists, brands, equipment — and leaves behind unprofitable divisions or obsolete assets.
Debt, litigation, and tax contingencies remain with the selling entity. The buyer is shielded from the target's history of obligations.
Acquired assets are stepped up to fair market value on the buyer's books, raising the depreciation base and generating meaningful tax savings over the following years.
Disadvantages
Contracts must be re-executed, permits re-obtained, and employees re-hired one by one. Post-close integration can take months.
The selling corporation pays corporate tax on the gain, then distributes the net proceeds to shareholders who owe dividend tax. Sellers resist this structure.
Drug approvals (FDA), broadcasting licenses, and financial licenses are often non-transferable. Asset deals may not work at all in heavily regulated industries.
Why tax is the real driver of structure
The biggest point of conflict in any deal structure negotiation is taxes. Sellers and buyers have directly opposing interests.
Seller's preference
Stock Deal
Individual shareholders pay only capital gains tax on the proceeds. An asset deal forces the corporation to pay corporate tax on the gain, then subjects shareholders to a second layer of dividend tax when they take the money out.
Buyer's preference
Asset Deal
Assets are stepped up to fair market value on the buyer's books (tax step-up). Higher depreciation base = significant tax savings in the years ahead. Stock deals carry over the target's original book values and provide none of this benefit.
🔑 Key insight
Deal structure creates a direct conflict between seller and buyer on tax. The most common resolution is a price adjustment for the tax differential — if the seller accepts an asset deal, the buyer compensates them with a higher price that offsets the extra tax burden. Which structure "wins" is ultimately a question of whose after-tax economics are better under which scenario.
When to use each structure
Beyond tax, there are practical factors that push deals toward one structure or the other.
| Situation | Structure |
|---|---|
| Target has significant debt or litigation risk | Asset Deal |
| Key licenses are tied to the corporate entity | Stock Deal |
| Buying only part of a business | Asset Deal |
| PE exit — founder wants a clean exit | Stock Deal |
| Pharmaceutical or regulated-industry acquisition | Stock Deal |
| Distressed-asset purchase | Asset Deal |
Real-world case examples
The right structure depends on the industry and the specific deal. Here are three examples.
Pharma company acquisition
Stock DealFDA new-drug approvals, clinical data packages, and GMP certifications are attached to the legal entity. Transferring them as assets is either impossible or takes years to re-approve.
Distressed company asset purchase
Asset DealThe buyer acquires equipment, technology, and customer relationships from a company loaded with debt. The liabilities stay with the bankrupt entity; the buyer takes only the operational value.
Corporate division carve-out
Asset Deal / Carve-outA parent company sells off a business unit by transferring its assets, contracts, and headcount. Often structured as a carve-out: a new entity is first spun off, then its shares are sold — a hybrid of both approaches.